Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dancing | 6 | 2024 | 104 | 1.420 |
Why?
|
Gossypol | 6 | 2015 | 23 | 0.970 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2015 | 1404 | 0.690 |
Why?
|
Athletic Injuries | 6 | 2020 | 1216 | 0.620 |
Why?
|
Adolescent Development | 1 | 2020 | 282 | 0.560 |
Why?
|
Minocycline | 1 | 2015 | 169 | 0.450 |
Why?
|
Hallux | 2 | 2021 | 43 | 0.360 |
Why?
|
Pancreatic Neoplasms | 5 | 2015 | 5366 | 0.360 |
Why?
|
Mental Health | 1 | 2020 | 3251 | 0.260 |
Why?
|
Interleukins | 5 | 2015 | 782 | 0.260 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 422 | 0.260 |
Why?
|
Adenoviridae | 4 | 2015 | 1084 | 0.250 |
Why?
|
Sleep | 1 | 2020 | 4761 | 0.240 |
Why?
|
Gene Silencing | 1 | 2009 | 1496 | 0.220 |
Why?
|
BRCA1 Protein | 1 | 2009 | 1149 | 0.210 |
Why?
|
Sesamoid Bones | 1 | 2021 | 14 | 0.190 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2813 | 0.180 |
Why?
|
Basketball | 1 | 2021 | 46 | 0.180 |
Why?
|
Oncolytic Viruses | 2 | 2015 | 344 | 0.180 |
Why?
|
Gene Transfer Techniques | 3 | 2014 | 1201 | 0.170 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2009 | 2914 | 0.160 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2015 | 3591 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2015 | 11732 | 0.160 |
Why?
|
Soccer | 1 | 2021 | 142 | 0.160 |
Why?
|
Platelet-Rich Plasma | 1 | 2021 | 178 | 0.160 |
Why?
|
Sports Medicine | 1 | 2021 | 239 | 0.150 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13630 | 0.150 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6340 | 0.140 |
Why?
|
Drug Design | 2 | 2012 | 1045 | 0.140 |
Why?
|
Running | 1 | 2021 | 487 | 0.140 |
Why?
|
Apoptosis | 5 | 2015 | 9478 | 0.130 |
Why?
|
Cell Line, Tumor | 9 | 2015 | 16947 | 0.130 |
Why?
|
Ovarian Neoplasms | 2 | 2009 | 4853 | 0.130 |
Why?
|
Tarsal Joints | 1 | 2015 | 32 | 0.130 |
Why?
|
Receptor, EphA2 | 1 | 2015 | 41 | 0.130 |
Why?
|
Nitrophenols | 1 | 2015 | 169 | 0.120 |
Why?
|
Tarsal Bones | 1 | 2015 | 70 | 0.120 |
Why?
|
Range of Motion, Articular | 2 | 2019 | 1590 | 0.120 |
Why?
|
Ankle Joint | 1 | 2019 | 446 | 0.120 |
Why?
|
Tetracycline | 1 | 2015 | 216 | 0.120 |
Why?
|
Muscle Strength | 1 | 2019 | 624 | 0.120 |
Why?
|
Poly I-C | 1 | 2014 | 112 | 0.120 |
Why?
|
Drug Synergism | 2 | 2015 | 1756 | 0.110 |
Why?
|
Foot Injuries | 1 | 2015 | 149 | 0.110 |
Why?
|
Mice, Nude | 6 | 2015 | 3604 | 0.110 |
Why?
|
Post-Concussion Syndrome | 1 | 2016 | 243 | 0.110 |
Why?
|
Oncolytic Virotherapy | 2 | 2015 | 515 | 0.100 |
Why?
|
Syntenins | 1 | 2012 | 8 | 0.100 |
Why?
|
Hip Joint | 1 | 2019 | 1014 | 0.100 |
Why?
|
Neoplasms | 4 | 2012 | 22125 | 0.090 |
Why?
|
Biphenyl Compounds | 1 | 2015 | 1007 | 0.090 |
Why?
|
Knee Joint | 1 | 2019 | 1677 | 0.090 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 714 | 0.090 |
Why?
|
Mouth Neoplasms | 1 | 2015 | 596 | 0.090 |
Why?
|
Receptors, Virus | 1 | 2012 | 642 | 0.080 |
Why?
|
Animals | 14 | 2015 | 168083 | 0.070 |
Why?
|
Paclitaxel | 1 | 2015 | 1730 | 0.070 |
Why?
|
Integrases | 1 | 2009 | 518 | 0.070 |
Why?
|
Prostatic Neoplasms | 3 | 2015 | 11103 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 2 | 2015 | 4510 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8519 | 0.060 |
Why?
|
Motor Activity | 1 | 2016 | 2712 | 0.060 |
Why?
|
Genomic Instability | 1 | 2009 | 709 | 0.060 |
Why?
|
Sulfonamides | 1 | 2015 | 1977 | 0.060 |
Why?
|
Interleukin-10 | 1 | 2010 | 1176 | 0.060 |
Why?
|
Humans | 26 | 2024 | 761098 | 0.060 |
Why?
|
Adolescent | 6 | 2024 | 88271 | 0.060 |
Why?
|
Mice | 8 | 2015 | 81324 | 0.060 |
Why?
|
Athletes | 2 | 2021 | 1138 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2014 | 1726 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13362 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2015 | 5103 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2015 | 8529 | 0.050 |
Why?
|
Genetic Engineering | 1 | 2007 | 929 | 0.050 |
Why?
|
Cell Membrane | 1 | 2009 | 3665 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4021 | 0.040 |
Why?
|
Hip Injuries | 1 | 2020 | 79 | 0.040 |
Why?
|
Weight Lifting | 1 | 2020 | 130 | 0.040 |
Why?
|
Specialization | 1 | 2024 | 778 | 0.040 |
Why?
|
Alleles | 1 | 2009 | 6857 | 0.040 |
Why?
|
Joints | 1 | 2020 | 322 | 0.040 |
Why?
|
Pelvic Bones | 1 | 2020 | 270 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2009 | 3666 | 0.040 |
Why?
|
Spinal Injuries | 1 | 2020 | 300 | 0.030 |
Why?
|
Female | 12 | 2024 | 392458 | 0.030 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2015 | 17 | 0.030 |
Why?
|
Child | 5 | 2024 | 80134 | 0.030 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2015 | 37 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 5750 | 0.030 |
Why?
|
Knee Injuries | 1 | 2020 | 488 | 0.030 |
Why?
|
Protein Modification, Translational | 1 | 2014 | 21 | 0.030 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2015 | 85 | 0.030 |
Why?
|
Cell Survival | 2 | 2015 | 5776 | 0.030 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 61 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2015 | 410 | 0.030 |
Why?
|
Drug Delivery Systems | 2 | 2015 | 2223 | 0.030 |
Why?
|
Male | 11 | 2021 | 360675 | 0.030 |
Why?
|
Serotyping | 1 | 2014 | 325 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2015 | 321 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5694 | 0.030 |
Why?
|
RNA, Double-Stranded | 1 | 2014 | 290 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2015 | 5775 | 0.030 |
Why?
|
Chemoprevention | 1 | 2014 | 325 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6919 | 0.020 |
Why?
|
Syndecans | 1 | 2012 | 75 | 0.020 |
Why?
|
Gelatinases | 1 | 2012 | 88 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2015 | 561 | 0.020 |
Why?
|
Quinolones | 1 | 2015 | 378 | 0.020 |
Why?
|
Enzyme Precursors | 1 | 2012 | 167 | 0.020 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2012 | 120 | 0.020 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2012 | 145 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2015 | 13404 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2393 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 1074 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1138 | 0.020 |
Why?
|
Cytoplasm | 1 | 2014 | 1498 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 987 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2012 | 448 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2015 | 9518 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1892 | 0.020 |
Why?
|
Rats | 2 | 2015 | 23713 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2114 | 0.020 |
Why?
|
Fracture Fixation, Internal | 1 | 2015 | 971 | 0.020 |
Why?
|
Transgenes | 1 | 2012 | 1008 | 0.020 |
Why?
|
Nervous System | 1 | 2012 | 545 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18217 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 59199 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2012 | 1225 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2012 | 931 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2138 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2816 | 0.020 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2007 | 257 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6198 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2007 | 914 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10552 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3409 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2007 | 302 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2475 | 0.020 |
Why?
|
Receptors, Peptide | 1 | 2007 | 279 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 1113 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2014 | 2194 | 0.020 |
Why?
|
Piperazines | 1 | 2015 | 2522 | 0.010 |
Why?
|
Self Report | 1 | 2016 | 3728 | 0.010 |
Why?
|
Gadolinium DTPA | 1 | 2007 | 823 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6507 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 39953 | 0.010 |
Why?
|
Adult | 4 | 2020 | 221083 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2726 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18385 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26068 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10755 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12951 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2802 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 80673 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 36418 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15717 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 74219 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 7844 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17598 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2012 | 5300 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39121 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2015 | 64670 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9455 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54419 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41486 | 0.010 |
Why?
|
United States | 1 | 2020 | 72337 | 0.010 |
Why?
|
Disease Progression | 1 | 2007 | 13506 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22129 | 0.000 |
Why?
|
Signal Transduction | 1 | 2012 | 23415 | 0.000 |
Why?
|
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_